Patents by Inventor Barbara D'Angelo

Barbara D'Angelo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticles of cerium oxide targeted to an amyloid beta antigen of alzheimer's disease and associated methods
    Patent number: 9463253
    Abstract: Disclosed is a composition immunologically targeted to Alzheimer's disease (AD), the composition containing amine functionalized nanoparticles of Cerium oxide coated with polyethylene glycol and bearing an antibody specific for an amyloid-beta antigen associated with AD. The invention also includes a medication manufactured with the targeted nanoceria particles and methods of treatment by administering the targeted nanoceria particles to patients in need thereof.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: October 11, 2016
    Assignees: University of Central Florida Research Foundation, Inc., University of L'Aquila
    Inventors: Sudipta Seal, Soumen Das, Annamaria Cimini, Barbara D'Angelo
  • Nanoparticles of Cerium Oxide Targeted to an Amyloid Beta Antigen of Alzheimer's Disease and Associated Methods
    Publication number: 20150118316
    Abstract: Disclosed is a composition immunologically targeted to Alzheimer's disease (AD), the composition containing amine functionalized nanoparticles of Cerium oxide coated with polyethylene glycol and bearing an antibody specific for an amyloid-beta antigen associated with AD. The invention also includes a medication manufactured with the targeted nanoceria particles and methods of treatment by administering the targeted nanoceria particles to patients in need thereof.
    Type: Application
    Filed: November 3, 2014
    Publication date: April 30, 2015
    Applicants: University of Central Florida Research Foundation, Inc., University of L'Aquila
    Inventors: Sudipta Seal, Soumen Das, Annamaria Cimini, Barbara D'Angelo
  • Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of Alzheimer's disease and associated methods
    Patent number: 8877207
    Abstract: Disclosed is a composition immunologically targeted to Alzheimer's disease (AD), the composition containing amine functionalized nanoparticles of Cerium oxide coated with polyethylene glycol and bearing an antibody specific for an amyloid-beta antigen associated with AD. The invention also includes a medication manufactured with the targeted nanoceria particles and methods of treatment by administering the targeted nanoceria particles to patients in need thereof.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: November 4, 2014
    Assignees: University of Central Florida Research Foundation, Inc., University of l'Aquila
    Inventors: Annamaria Cimini, Barbara D'Angelo, Soumen Das, Sudipta Seal
  • Nanoparticles Of Cerium Oxide Targeted To An Amyloid-Beta Antigen Of Alzheimer's Disease And Associated Methods
    Publication number: 20120070500
    Abstract: Disclosed is a composition immunologically targeted to Alzheimer's disease (AD), the composition containing amine functionalized nanoparticles of Cerium oxide coated with polyethylene glycol and bearing an antibody specific for an amyloid-beta antigen associated with AD. The invention also includes a medication manufactured with the targeted nanoceria particles and methods of treatment by administering the targeted nanoceria particles to patients in need thereof.
    Type: Application
    Filed: July 18, 2011
    Publication date: March 22, 2012
    Inventors: Annamaria Cimini, Barbara D'Angelo, Soumen Das, Sudipta Seal